Cederroth Competitors and Similar CompaniesClear all
Cederroth's competitors and similar companies include Sun Pharma, Aspetar, Adamis Pharmaceuticals and Rusan Pharma.
 Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. |  Adamis Pharmaceuticals Adamis Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease. | ||||
Founding Date | Founding Date 1970 | Founding Date 1983 | Founding Date 2007 | Founding Date 2006 | Founding Date 1994 |
Type | Type Subsidiary | Type Public | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Solna, SE HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more | Locations Doha, QA HQ | Locations San Diego, US HQ | Locations Mumbai, IN HQ Gandhidham, IN |
Employees | Employees 103 | Employees 43,000 | Employees 8651% increase | Employees 15241% increase | Employees 543 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹582.2b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) $4.8m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ₹115.4b (FY, 2026) | Cost of goods N/A | Cost of goods $6.2m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ₹488.9b (FY, 2026) | Gross profit N/A | Gross profit ($1.4m) (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income ₹115.6b (FY, 2026) | Net income N/A | Net income ($26.5m) (FY, 2022) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Sun Pharma
HQ
Mumbai, IN
Employees
43,000
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company
Aspetar
HQ
Doha, QA
Employees
865↑ 1% increase
Aspetar is an orthopedic and sports medicine hospital.
View companyAdamis Pharmaceuticals
HQ
San Diego, US
Adamis Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease.
View company